Access to Information Requests Completed - September 2011

This content was archived on June 24, 2013.

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

Completed Requests

For the month of September 2011

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2008-00462	Subsequent to the conclusion of the court case, Regina vs. The Synergy Group of Canada Inc. All documents of all government departments and agencies specifically regarding the Synergy Group of Canada Inc., Truehope Nutritional Support Ltd, and EMPowerplus®. (Jul 28, 2006 to Aug 20, 2008).	Disclosed in part	727
A-2008-01112	All documents regarding RetroFoam insulation illegally sold in Canada.	Disclosed in part	871
A-2009-00514	Research and reports on potential hazards associated with cosmetics. (Jan 1, 2009 to Jul 10, 2009).	Disclosed in part	115
A-2009-00544	Information regarding the product Velcade (bortezomib), DIN 02230508 by JANSSEN-ORTHO INC.	Disclosed in part	1,492
A-2009-00736	Information regarding the herb stevia.	Disclosed in part	204
A-2009-00740	Information regarding the herb stevia.	Disclosed in part	527
A-2009-01306	Information regarding the product Resultz.	Disclosed in part	484
A-2010-00039	All records related to a bioequivalence trial for bicalutamide (Casodex) sponsored by Genpharm and conducted by Anapharm in September 2005. (Aug 5, 2005 to Apr 1, 2006).	Disclosed in part	89
A-2010-00069	All records regarding the Royal Canadian Mounted Police's 2009 review of the medical marihuana access program.	Disclosed in part	49
A-2010-00093	Information relating to the Irn-Bru (carbonated soft drink) submission to Health Canada regarding caffeine.	Disclosed in part	689
A-2010-00181	All documents regarding National Coordination Center Risk Management Committee and or Community of Federal Regulators pertaining to Mr. Richard Beemer or his company BIE Health Products. (Jan 1, 2004 to May 12, 2010).	Disclosed in part	158
A-2010-00186	Information regarding the product APO-PANTOPRAZOLE, DIN 02292920 by APOTEX INC.	Disclosed in part	870
A-2010-00238	All documents that reference Orange TKO, Orange TKO Super Concentrated Cleaner, Orange TKO Industries International Inc, Orange Organic TKO, Organic Orange TKO Industries International. (Jan 1, 2009 to Jun 1, 2010).	Disclosed in part	339
A-2010-00335	Information regarding the products SEASONALE (DIN 02296659) and SEASONIQUE (DIN 02346176).	Disclosed in part	988
A-2010-00577	Information regarding the product Polyride-Fe Capsules, NPN 80020979.	Disclosed in part	23
A-2010-00752	All reports on the safety assessment of lasalocid sodium for the establishment of Maximum Residue Limits in edible tissues of food animals treated with lasalocid sodium in feeds.	Disclosed in part	63
A-2010-00948	Job description for a Therapeutics Products Directorate, Health Products & Food Branch, Medical Devices Bureau position number HFHDM-2009 that was in effect for June 3, 2008.	All disclosed	13
A-2010-01041	All documents on Health Canada's decision to focus on contraband tobacco (announced to provincial territorial Health Ministers September 2010). (Sep 1, 2009 to Jan 10, 2011).	Disclosed in part	158
A-2010-01070	Information relating the public involvement activities undertaken by Health Products and Food Branch. (Jan 1, 2004 to Dec 21, 2010).	Disclosed in part	237
A-2010-01163	All documents by Health Canada from the Non-Smokers Rights Association. (Oct 15, 2008 to Jan 20, 2011).	Disclosed in part	487
A-2010-01168	All correspondence to/from Health Canada and the Canadian Council for Tobacco Control. (Oct 15, 2008 to Jan 20, 2011).	Disclosed in part	1,282
A-2010-01171	All correspondence to/from Health Canada and the Québec Coalition for Tobacco Control. (Oct 15, 2008 to Jan 20, 2011).	Disclosed in part	261
A-2010-01198	Cash Flow Statement submitted by Canada Health Infoway Inc.	Disclosed in part	3
A-2010-01249	Information regarding the product Grape Seed Complex, Vita Aid, NPN 80015989 by Naturo Aid Pharmaceutical Inc.	Disclosed in part	129
A-2010-01284	Information regarding the medical device PreVu Point of Care, License number 65989 by PreMD Inc.	Disclosed in part	80
A-2010-01402	All information regarding Salvia divinorum.	Disclosed in part	3,136
A-2010-01453	Information for the medical device PreVu Point of Care, License number 65989 by PreMD Inc.	Disclosed in part	18
A-2010-01552	Information regarding the product Naloxone HCI Injection 0.4 mg/mL, DIN 02148706 by Sandoz Canada Inc.	Disclosed in part	65
A-2010-01555	Information regarding the product Labetalol Hydrochloride Injection USP, DIN 02231689 by Sandoz Canada Inc.	Disclosed in part	1,195
A-2010-01584	Information regarding the product Lutein, NPN 80006091 by Purity Life Health Products.	Disclosed in part	83
A-2011-00001	All documents to support the authorisation of DIOR-Drug Eluting Ballon (DEB) under the special access program and Investigational Authorization.	Disclosed in part	467
A-2011-00045	Information regarding the medical device license number 61613 by Dentsply Tulsa Dental.	Disclosed in part	19
A-2011-00072	Information regarding the product MUSCLE & BACK PAIN RELIEF CAPLETS, DIN 02230790 by VITA HEALTH PRODUCTS Inc.	Disclosed in part	14
A-2011-00088	All documents in the custody of Labour Relations-Operations pertaining to Simian Foamy Virus (SFV) testing/retesting. (Jan 01, 2008 to Apr 15, 2011).	Disclosed in part	147
A-2011-00090	Documents explaining the department's decision to commission The study of Investigation of children's exposure to chemical in indoor dust, and why the department felt the need to commission the study in the first place.	Disclosed in part	79
A-2011-00096	All documents to the submission made by Pioneer Hi- Bred Production Ltd. for food approval for the High Oleic Soybean Event 305423.	Disclosed in part	3,585
A-2011-00099	All inspection reports done on hospitals that comes under the Regulations for Cells, Tissues and Organs Act.	Disclosed in part	761
A-2011-00100	Information on a gap analysis report completed by Health Canada to respond to the cuts to the Aboriginal Healing Foundation.	Disclosed in part	707
A-2011-00109	All documentation pertaining to project or program funding agreements with and subsequent deliverables to Health Canada by: Action on Smoking and Health - Alberta (ASH Alberta).	Disclosed in part	38
A-2011-00117	Information regarding the product Sunscreen lotion écran solaire 30, DIN 02230861.	Disclosed in part	27
A-2011-00125	Product Monograph for the following products: - Novoxapam tablets, DINs 00500852, 00496529 and 00496537 by Novopharm limited. - PMS-Oxazepam tablets, DINs 00726362, 00726370 and 00726389 by Phamascience Inc.	All disclosed	16
A-2011-00128	Information regarding the product Tilmovet Premix, DIN 02230861 by Huvepharma AD.	Disclosed in part	336
A-2011-00133	AERs for the product Celexa. Report numbers: 000353508, 000355156, 000357730 and 000359013.	Disclosed in part	20
A-2011-00144	Various documents relating to Chrysotile Asbestos.	Disclosed in part	271
A-2011-00148	All documents pertaining to complaints, compliance actions, interdepartmental communications regarding products by Sister Lotus, Angie Jenkins, Angie Oriana Jenkins, or any product sold under this label or claimed to be manufactured/sold under this name/label.	Disclosed in part	118
A-2011-00199	All documents from tobacco manufactures concerning possible changes to health warnings and / or other packaging and labelling requirements for tobacco products in response to draft regulations published in the Canada Gazette, Part 1 on February 19, 2011.	Disclosed in part	262
A-2011-00201	All documents from the tobacco industry other than tobacco manufacturers concerning possible changes to health warnings and / or other packaging and labelling requirements for tobacco products in response to draft regulations published in the Canada Gazette, Part 1 on February 19, 2011.	Disclosed in part	54
A-2011-00216	Copies of Drug Offence/Disposition Reports (HC/SC 3515) that Health Canada received from the Sureté du Québec between April 1, 2010, and March 31, 2011.	Disclosed in part	364
A-2011-00279	Number of SAP releases for the following drug for the year 2010: Folotyn (Pralatrexate).	All disclosed	1
A-2011-00280	Number of SAP releases for the following drug for the year 2010: Prochymal (Remestemcel-L).	No records exist	0
A-2011-00281	Number of SAP releases for the following drug for the year 2010: Targretin (Bexaretene).	All disclosed	1
A-2011-00282	Number of SAP releases for the following drug for the year 2010: Treanda (Bendamustine).	All disclosed	1
A-2011-00283	Number of SAP releases for the following drug for the year 2010: Carfilzomib.	No records exist	0
A-2011-00284	Number of SAP releases for the following drug for the year 2010: Cabazitaxel (Jevtana).	All disclosed	1
A-2011-00285	Number of SAP releases for the following drug for the year 2010: Halaven (Eribulin Mesylate).	All disclosed	1
A-2011-00286	AERs for the product Humira. Report numbers: 000355528, 000355875, 000357110 and 000357220.	Disclosed in part	7
A-2011-00304	All documents from the Minister, Parliamentary Secretary and/or Health Canada Department officials to provincial counterparts related to the Common Purchasing Alliance for Drugs/Pharmaceuticals and Medical Supplies/Devices. (May 1, 2010 to Jun 6, 2011).	All disclosed	15
A-2011-00315	All documents regarding the success or failures of controlling precursors [ephedrine and pseudoephedrine] for the illegal production of methamphetamine. (Jan 2010 to Jun 1, 2011).	All disclosed	63
A-2011-00337	All documents prepared for the Minister of Health and the Chief Public Health Officer relating to the MV Sun Sea, which arrived in British Columbia on August 13, 2010. (Jun 1, 2010 to Jun 1, 2011).	All disclosed	157
A-2011-00389	Phone records involving the Health Canada's office telephone line and any cellular device specifically for the manager of Finance of Toronto Region under the Regions & Programs Branch of Health Canada. (Jun 22, 2010 to Mar 24, 2011).	Disclosed in part	60
A-2011-00393	Electronic copy of the data contained in the Product Safety Information System maintained by the National Compliance and Information Systems Division of the Consumer Product Safety Bureau.	Disclosed in part	19,440
A-2011-00405	All documents in MECS for the following files: 11-102396-12, 10-124276-177, 10-124276-177.	Disclosed in part	10
A-2011-00407	All documents in MECS for the following files: 10-122836-820 (Drug Treatment Funding Program).	Disclosed in part	50
A-2011-00410	All documents in MECS for the following files: 11-100384-789.	All disclosed	11
A-2011-00413	All documents in MECS for the following files: 10-126104-840.	All disclosed	113
A-2011-00473	Provide following correspondence sent and received by Doug Mercer. (May 2, 2011 to May 31, 2011).	Disclosed in part	685
A-2011-00480	All documents with regards to Health Minister meeting in St. John's Newfoundland on Sept 13-14, 2010 relating to Chronic cerebrospinal venous insufficiency (CCSVI).	Disclosed in part	23
A-2011-00486	Per quarter sales of various Tobacco products. (Jan 1, 2001 to Mar 30, 2011).	All disclosed	15
A-2011-00494	Product Monograph for Heparin sodium injection USP, DINs 02303094, 02303086 and 02303108 by Sandoz Canada Inc.	All disclosed	3
A-2011-00501	Information regarding the product APO HYDRO TAB, DINs 00312800 and 00644552 by Apotex Inc.	No records exist	0
A-2011-00551	The list of studies, reports and other supporting documents that are no longer data protected used and available to be cited that were used to register triclosan (CAS #3380-34-5) as a technical active ingredient under the Pest Control Products Act.	All disclosed	8
A-2011-00552	nt listing the affiliations and interests of members of the Scientific Advisory Panel on Bioequivalence Requirements for Gender Specific Drug Products.	Disclosed in part	53
A-2011-00553	Full report of the discussions in the teleconference meeting of the Scientific Advisory Panel on Bioequivalence Requirements for Gender Specific Drug Products held on June 2, 2011.	Disclosed in part	5
A-2011-00567	Product Monograph for LORAZEPAM INJECTION USP 4MG/ ML, DIN 02243278 by Sandoz Canada Inc.	All disclosed	20
A-2011-00589	Provide total amount paid to retailers, by province, by tobacco manufacturers and importers per clause 22(b) of the Tobacco Reporting Regulations. (January 2010 to June 2011).	No records exist	0
A-2011-00593	Provide total cost of all advertisements in publications reported by tobacco manufacturers and importers under subsection 16(1) and section 17 of the Tobacco Reporting Regulations. (January 2010 to June 2011).	No records exist	0
A-2011-00594	Provide total cost of all promotional activities reported by tobacco manufacturers and importers under subsection 16(2) of the Tobacco Reporting Regulations. (January 2010 to June 2011).	No records exist	0
A-2011-00595	Provide reports submitted by every tobacco manufacturer and importer under subsection 16(1) of the Tobacco Reporting Regulations. (January 2010 to June 2011).	No records exist	0
A-2011-00612	All documents related to the processing of the Access to Information request A-2010-00738.	Disclosed in part	108
A-2011-00616	AER. Report number: 000359700.	Disclosed in part	1
A-2011-00622	All records related to United States Food and Drug Administration, HPFB and CFIA working group tasked with facilitating harmonization of Front of pack labelling policies. (Jul 1, 2010 to Aug 18, 2011).	No records exist	0
A-2011-00624	All agendas, minutes and supporting documents of the Healthy Foods Working Group. (Feb 11, 2011 to Aug 18, 2011).	No records exist	0
A-2011-00625	Attachment MinDM Energy Drinks (Nov 20, 2010)_steph_Nov21_1400h.ppt deleted by Meena Ballantyne/HC-SC/GC/CA from Access to Information request A-2010-01261.	Disclosed in part	19
A-2011-00626	A listing of the Access to Information requests submitted to Health Canada. (Jul 1, 2011 to Jul 31, 2011).	All disclosed	11
A-2011-00630	AER for the product TEMODAL. Report number: 000329623.	Disclosed in part	2
A-2011-00631	AERs for the product CLARITIN. Report numbers: 000310741, 000302400, 000302566, 000323542, 000308936 and 000309495.	Disclosed in part	6
A-2011-00632	AER for the product ESTROGEL. Report number: 000359592.	Disclosed in part	1
A-2011-00634	AER for the product Extra Strength Tylenol. Report number: 000368743.	Disclosed in part	7
A-2011-00638	Information regarding the Wind Turbine Noise Working Group of the FPT Committee on Health and the Environment.	Disclosed in part	9
A-2011-00652	AER for the product WinRho SDF. Report number: 000359599.	Disclosed in part	5
A-2011-00659	All documents of adverse reactions/events reported following the administration of Act-HIB (DIN 01959034) and DPT Polio adsorbed (DIN 00605050) to all children in Canada. This combination was marketed as Penta + administration between 1993 and 1998.	No records exist	0
A-2011-00661	A listing of the Access to Information requests submitted to Health Canada. (Aug 1, 2011 to Aug 31, 2011).	Disclosed in part	9
A-2011-00666	All documents regarding the International Narcotics Control Board (INCB) concerning the January 2010 earthquake in Haiti. (January to March 2010).	No records exist	0
A-2011-00667	All documents pertaining to the transfer or shipment of controlled opioid narcotics, analgesics, or analgesics from Canada to Haiti for the humanitarian purposes in the wake of the January 2010 earthquake. (January to March 2010).	No records exist	0
A-2011-00670	Package Insert for the product Heparin Leo, DINs 00727520, 00579718, 00453811 and 00453781 by Leo Pharma.	No records exist	0
A-2011-00679	All call-ups processed by this institution in the National Capital Region under the terms of the any standing offer or supply arrangement for Temporary Help Services during the period of August 2011.	Disclosed in part	36
A-2011-00680	All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of August 2011.	All disclosed	2
A-2011-00681	Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during August 2011.	All disclosed	4
A-2011-00682	All call-ups and amendments issued under the terms of the TBIPS Standing Offer (EN578-055605) in the National Capital Region during the month of August 2011.	No records exist	0
A-2011-00694	Information regarding the amount of legal fees and other costs associated with any and all legal proceedings commenced under the Access to Information Act for the last twenty years.	No records exist	0
A-2011-00695	Information regarding the product Oxyneo by Purdue Pharma.	All exempted	0